Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020;27(5):533-540.
doi: 10.5603/CJ.a2020.0072. Epub 2020 May 21.

Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey

Piotr Jankowski  1 , Dariusz A Kosior  2   3 , Paweł Sowa  4 , Karolina Szóstak-Janiak  5 , Paweł Kozieł  6 , Agnieszka Krzykwa  3 , Emilia Sawicka  4 , Maciej Haberka  5 , Małgorzata Setny  3 , Karol Kamiński  4 , Zbigniew Gąsior  5 , Aldona Kubica  7 , Dirk De Bacquer  8 , Guy De Backer  8 , Kornelia Kotseva  9 , David Wood  9 , Andrzej Pająk  10 , Danuta Czarnecka  6
Affiliations
Multicenter Study

Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey

Piotr Jankowski et al. Cardiol J. 2020.

Abstract

Background: The highest priority in preventive cardiology is given to patients with established coronary artery disease (CAD). The aim of the study was to assess the current implementation of the guidelines for secondary prevention in everyday clinical practice by evaluating control of the main risk factors and the cardioprotective medication prescription rates in patients following hospitalization for CAD.

Methods: Fourteen departments of cardiology participated in the study. Patients (aged ≤ 80 years) hospitalized due an acute coronary syndrome or for a myocardial revascularization procedure were recruited and interviewed 6-18 months after the hospitalization.

Results: Overall, 947 patients were examined 6-18 months after hospitalization. The proportion of patients with high blood pressure (≥ 140/90 mmHg) was 42%, with high low-density lipoprotein cholesterol (LDL-C ≥ 1.8 mmol/L) 62%, and with high fasting glucose (≥ 7.0 mmol/L) 22%, 17% of participants were smokers and 42% were obese. The proportion of patients taking an antiplatelet agent 6-18 months after hospitalization was 93%, beta-blocker 89%, angiotensin converting enzyme inhibitor or sartan 86%, and a lipid-lowering drug 90%. Only 2.3% patients had controlled all the five main risk factors well (non-smoking, blood pressure < 140/90 mmHg, LDL-C < 1.8 mmol/L and glucose < 7.0 mmol/L, body mass index < 25 kg/m2), while 17.9% had 1 out of 5, 40.9% had 2 out of 5, and 29% had 3 out of 5 risk factors uncontrolled.

Conclusions: The documented multicenter survey provides evidence that there is considerable potential for further reductions of cardiovascular risk in CAD patients in Poland. A revision of the state funded cardiac prevention programs seems rational.

Keywords: coronary artery disease; hypercholesterolemia; hypertension; risk factors; secondary prevention; smoking.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1
Figure 1
Distribution of the secondary prevention coefficient values.
See this image and copyright information in PMC

References

    1. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. - PMC - PubMed
    1. Gierlotka M, Zdrojewski T, Wojtyniak B, et al. Incidence, treatment, in-hospital mortality and one-year outcomes of acute myocardial infarction in Poland in 2009–2012 — nationwide AMI-PL database. Kardiol Pol. 2015:142–158. doi: 10.5603/kp.a2014.0213. - DOI - PubMed
    1. Jankowski P, Gąsior M, Gierlotka M, et al. Coordinated care after myocardial infarction. The statement of the Polish Cardiac Society and the Agency for Health Technology Assessment and Tariff System. Kardiol Pol. 2016:800–811. doi: 10.5603/kp.2016.0118. - DOI - PubMed
    1. Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2015;23(6):636–648. doi: 10.1177/2047487315569401.. - DOI - PubMed
    1. Kotseva K, De Backer G, De Bacquer D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26(8):824–835. doi: 10.1177/2047487318825350. - DOI - PubMed

Publication types